Lameijer, Joost R. C. http://orcid.org/0000-0002-1783-500X
Voogd, Adri C.
Pijnappel, Ruud M.
Setz-Pels, Wikke
Broeders, Mireille J.
Tjan-Heijnen, Vivianne C. G.
Duijm, Lucien E. M.
Article History
Received: 15 October 2019
Revised: 3 April 2020
Accepted: 15 April 2020
First Online: 11 May 2020
Ethics approval and consent to participate
: The Dutch Central Committee on Research Involving Human Subjects the Netherlands (CCMO) is the National Competent Authority supervising the ethical review of trials performed within the Netherlands. They have confirmed that approval for this study was not necessary. The descriptive study has been set up complementary to a screening program for which the Dutch Health Care Minister has provided a permit. As the subjects included in the complementary trial did not undergo any additional burden, the Dutch Research Involving Human Subjects Act does not warrant ethical approval for the trial. This study was performed in accordance with the Declaration of Helsinki. All women except one (who was excluded) gave consent to participate in this study.
: Data are stored in a database maintained by one of the authors (L.E.M.D). The data are not publicly available. When data are needed, an official request can be made through the Department of Radiology of the Canisius Wilhelmina Hospital Nijmegen.
: The authors declare no competing interests.
: This research is funded by The Dutch Health Care Insurance Board, which also finances and provides national coordination for the breast cancer screening program.